King Pharmaceuticals KG Commercial Auto Liability — Total IBNR
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's commercial auto liability — total ibnr.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's commercial auto liability — total IBNR?
- King Pharmaceuticals (KG) reported commercial auto liability — total IBNR of 715,500,000% in Q4 2025.
- What does commercial auto liability — total IBNR mean?
- This represents the total Incurred But Not Reported (IBNR) reserves for the commercial auto liability segment. It captures the estimated liability for claims that have occurred but have not yet been reported to the insurer. This is a critical indicator of long-term reserve adequacy and actuarial estimation risk.